How does OET help for COPD?

COPD, chronic bronchitis, asthma or pulmonary emphysema usually result in measurable and noticeable symptoms due to reduced oxygen uptake in the blood, as well as a long-term loss of quality of life. OET against COPD: Oxygen energy therapy tackles the causes behind the symptoms and works to improve the function of the top-level control and regulation centre known as the autonomic nervous system. Better control at the “top” (the ANS) results in better functioning further “down”! (in the lung cells).

A placebo-controlled study involving COPD patients (pulmonary function with FEV1) as well as the experience gained over the past decade have shown that it is possible to verifiably improve lung function in COPD patients.
COPD patients with reduced oxygen saturation, e.g. 90% in the blood (as measured with a pulse oximeter finger clip), were able to increase their oxygen saturation levels by some 3-5% after just a few sessions of OET. Since OET does not supply any additional oxygen, this points to an improvement in the lung cells themselves. The empirical data and measurements combined with the results of the COPD study show that an improvement is still possible even in stage 4 COPD – despite the differing opinion of many “experts”. This should give those affected new hope. Many people can be helped by getting the comprehensive and independent information they need!

According to conventional doctrine, such results can only be achieved by:

  1. Increasing the oxygen concentration from, for example, 21% to 95% – 99% (oxygen concentrator or O2 bottle), or
  2. Increasing the air pressure (hyperbaric chamber) as is done in hyperbaric oxygen therapy (HBO)

But OET does not use either of these “coercive measures” yet still manages to increase oxygen saturation!

What is commonly known about COPD?

Chronic obstructive pulmonary disease (COPD) and chronic obstructive bronchitis are characterized by:

  • Chronic cough
  • Increased ejection
  • Difficulty in breathing

The consequences of COPD are:

  • Reduced oxygen uptake in the blood via the lung cells
  • Decreased energy production in the cells (in the mitochondria, the power plants of the cells), accompanied by poor physical fitness
  • Hyperinflation of lung cells with reduced gas exchange
  • Continuous phlegm formation which must be removed by coughing
  • Noticeable reduction of the quality of life and many restrictions in daily life
  • Progression of the disease with increased intake of medication

It is estimated that 3-5 million people in Germany, around 16 million people in the US and around 600 million people worldwide have COPD1. It is believed that this COPD will be the third leading cause of death by 2020.2 

1 Source: Wikipedia, October 2007.
2 Source: www.onmeda.de, August 2007.

Improve lung function in COPD and chronic bronchitis patients – with new approaches and new therapies.